J Morris

4.0k total citations · 1 hit paper
40 papers, 2.9k citations indexed

About

J Morris is a scholar working on Genetics, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, J Morris has authored 40 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 13 papers in Hematology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in J Morris's work include Hemoglobinopathies and Related Disorders (13 papers), Iron Metabolism and Disorders (11 papers) and Blood groups and transfusion (6 papers). J Morris is often cited by papers focused on Hemoglobinopathies and Related Disorders (13 papers), Iron Metabolism and Disorders (11 papers) and Blood groups and transfusion (6 papers). J Morris collaborates with scholars based in United Kingdom, Jamaica and Gambia. J Morris's co-authors include G. R. Serjeant, Peter Thomas, B. E. Serjeant, Brian Greenwood, G Char, B. Balkaran, David C. Kaslow, Anthony A. Holder, Eleanor M. Riley and Andrea Egan and has published in prestigious journals such as Science, The Lancet and Gut.

In The Last Decade

J Morris

39 papers receiving 2.7k citations

Hit Papers

A co-operative trial in the primary prevention of ischaem... 1978 2026 1994 2010 1978 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Morris United Kingdom 22 783 715 666 542 418 40 2.9k
Dees P. M. Brandjes Netherlands 35 762 1.0× 402 0.6× 1.0k 1.5× 762 1.4× 450 1.1× 100 4.1k
Ann M. Gronowski United States 32 263 0.3× 535 0.7× 362 0.5× 351 0.6× 316 0.8× 137 3.3k
Timo Möttönen Finland 37 503 0.6× 268 0.4× 1.1k 1.6× 408 0.8× 278 0.7× 114 4.6k
Michael F. Michelis United States 27 190 0.2× 124 0.2× 375 0.6× 410 0.8× 634 1.5× 97 3.2k
Lang Chen United States 40 342 0.4× 280 0.4× 995 1.5× 547 1.0× 1.1k 2.7× 113 4.6k
Hemant Kulkarni United States 38 157 0.2× 254 0.4× 210 0.3× 604 1.1× 739 1.8× 137 4.0k
M. S. R. Hutt United Kingdom 32 218 0.3× 542 0.8× 165 0.2× 633 1.2× 511 1.2× 135 3.3k
Christopher C. Dvorak United States 35 401 0.5× 583 0.8× 1.4k 2.1× 267 0.5× 1.1k 2.7× 173 4.4k
Suneeta Mittal India 25 130 0.2× 1.4k 1.9× 210 0.3× 427 0.8× 302 0.7× 123 3.0k
Hui‐Kim Yap Singapore 26 174 0.2× 158 0.2× 139 0.2× 341 0.6× 294 0.7× 141 2.3k

Countries citing papers authored by J Morris

Since Specialization
Citations

This map shows the geographic impact of J Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Morris more than expected).

Fields of papers citing papers by J Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Morris. The network helps show where J Morris may publish in the future.

Co-authorship network of co-authors of J Morris

This figure shows the co-authorship network connecting the top 25 collaborators of J Morris. A scholar is included among the top collaborators of J Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Morris. J Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Dall, Genevieve, Jessica Vieusseux, Kenneth S. Korach, et al.. (2017). SCA-1 Labels a Subset of Estrogen-Responsive Bipotential Repopulating Cells within the CD24 + CD49f hi Mammary Stem Cell-Enriched Compartment. Stem Cell Reports. 8(2). 417–431. 20 indexed citations
3.
Thame, M, Karlene Mason, Douglas R. Higgs, et al.. (2008). The red cell distribution width in sickle cell disease-is it of clinical value?. Clinical & Laboratory Haematology. 13(3). 229–237. 6 indexed citations
4.
Hornby, Peter A., et al.. (2006). A dental workforce review for a Midlands Strategic Health Authority. BDJ. 200(10). 575–579. 3 indexed citations
5.
Hawken, Mark, Hellen Meme, Jeremiah Chakaya, et al.. (1997). Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults. AIDS. 11(7). 875–882. 112 indexed citations
6.
Stormon, Michael, et al.. (1997). TYPHOID FEVER IN CHILDREN: DIAGNOSTIC AND THERAPEUTIC DIFFICULTIES. The Pediatric Infectious Disease Journal. 16(7). 713–714. 10 indexed citations
7.
Egan, Andrea, J Morris, G. Barnish, et al.. (1996). Clinical Immunity to Plasmodium falciparum Malaria Is Associated with Serum Antibodies to the 19-kDa C-Terminal Fragment of the Merozoite Surface Antigen, PfMSP-l. The Journal of Infectious Diseases. 173(3). 765–768. 271 indexed citations
8.
Hawken, Mark, Josephine C. Ojoo, J Morris, et al.. (1996). No increased prevalence of adrenocortical insufficiency in human immunodeficiency virus-associated tuberculosis. Tubercle and Lung Disease. 77(5). 444–448. 10 indexed citations
9.
Brennecke, Shaun P., MA Brown, CA Crowther, et al.. (1995). ASPIRIN AND PREVENTION OF PREECLAMPSIA. Australian and New Zealand Journal of Obstetrics and Gynaecology. 35(1). 8 indexed citations
10.
Sitas, Freddy, A. F. Fleming, & J Morris. (1994). Residual risk of transmission of HIV through blood transfusion in South Africa.. PubMed. 84(3). 142–4. 10 indexed citations
11.
Morris, J, et al.. (1994). Haematological risk factors for pregnancy outcome in Jamaican women with homozygous sickle cell disease. BJOG An International Journal of Obstetrics & Gynaecology. 101(9). 770–773. 15 indexed citations
12.
Serjeant, G. R., et al.. (1994). The painful crisis of homozygous sickle cell disease: clinical features. British Journal of Haematology. 87(3). 586–591. 105 indexed citations
13.
VESSEY, S. J. RUPERT, et al.. (1993). Laser photocoagulation for proliferative retinopathy in sickle haemoglobin C disease. Eye. 7(5). 703–706. 10 indexed citations
14.
Balkaran, B., G Char, J Morris, et al.. (1992). Stroke in a cohort of patients with homozygous sickle cell disease. The Journal of Pediatrics. 120(3). 360–366. 326 indexed citations
15.
Githui, W, P Nunn, E Juma, et al.. (1992). Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tubercle and Lung Disease. 73(4). 203–209. 60 indexed citations
16.
Christakis, John, N. Vavatsi, Maria Papadopoulou, et al.. (1991). A comparison of sickle cell syndromes in Northern Greece. British Journal of Haematology. 77(3). 386–391. 20 indexed citations
17.
Sackey, Kwesi, George T. Roberts, Andreas E. Kulozik, et al.. (1991). Two different forms of homozygous sickle cell disease occur in Saudi Arabia. British Journal of Haematology. 79(1). 93–98. 116 indexed citations
18.
Morris, J, David Dunn, Yvonne Grandison, et al.. (1991). The haematology of homozygous sickle cell disease after the age of 40 years. British Journal of Haematology. 77(3). 382–385. 27 indexed citations
19.
Christakis, John, Maria Papadopoulou, K. Mandraveli, et al.. (1990). Comparison of homozygous sickle cell disease in Northern Greece and Jamaica. The Lancet. 335(8690). 637–640. 30 indexed citations
20.
Oliver, M. F., J. A. Heady, J Morris, et al.. (1978). A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.. Heart. 40(10). 1069–1118. 701 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026